Phreesia Inc is a healthcare technology company that focuses on transforming the patient experience. It provides a software platform designed to streamline patient intake processes, enhance communication between patients and healthcare providers, and improve overall administrative efficiency within medical practices. By offering solutions such as patient surveys, appointment scheduling, and payment processing, Phreesia aims to optimize workflows, increase patient engagement, and ultimately contribute to better health outcomes. The company is committed to empowering both patients and providers through innovative technology that enhances the healthcare journey. Read More
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE:PHR) securities during the period of May 8, 2025 through March 30, 2026, inclusive (“the Class Period”).
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Phreesia (PHR) To Contact Him Directly To Discuss Their Options
Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Phreesia, Inc. (NYSE: PHR) between May 8, 2025 and March 30, 2026. Phreesia describes itself as a company that “provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.”
Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Phreesia, Inc. (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026. Phreesia provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.
NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal first quarter 2027 financial results after the close of market trading on Wednesday, May 27, 2026. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal first quarter results starting at 5PM Eastern Time on the same day.
NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Phreesia, Inc. (NYSE: PHR) resulting from allegations that Phreesia may have issued materially misleading business information to the investing public.
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Phreesia, a leader in patient intake, outreach and activation, has been named to Becker’s Hospital Review’s 2026 list of “Revenue Cycle Management Companies to Know.” The annual list recognizes companies that play a critical role in helping healthcare organizations manage the growing complexity of revenue cycle operations, including patient access, intake, billing and reimbursement.
MediFind, a leading data-powered online provider directory, is proud to announce it received the DiMe Seal, developed by the Digital Medicine Society (DiMe), an independent nonprofit advancing the safe and effective use of digital health. MediFind is the first doctor directory to be awarded this seal.
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHR) for violations of the securities laws.
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2026.
Phreesia, a leader in patient intake, outreach and activation, has been named one of Becker’s Healthcare’s Top Places to Work in Healthcare for 2026. This marks Phreesia’s second time being included on the list, which recognizes hospitals, health systems and healthcare companies that invest in their people through strong benefits, professional development and workplace practices that support engagement and retention.
Phreesia, a leader in patient intake, outreach and activation, and Sesame Workshop, the global nonprofit behind Sesame Street, received the Point of Care Excellence Award for their pediatric health and wellness campaign.
Phreesia, Inc. (NYSE: PHR) ("Phreesia" or the "Company") today announced the refinancing of its existing bridge loan (the “Bridge Loan”) by its entry into a new credit agreement providing for a senior secured revolving credit facility (the "New Credit Facility") of up to $275 million in aggregate principal amount, with Capital One, National Association (“Capital One”) serving as agent for the lenders. The Company borrowed approximately $92.2 million under the New Credit Facility at closing and used the proceeds to repay all outstanding indebtedness and obligations under the Bridge Loan, which was terminated without penalty. Remaining availability under the New Credit Facility may be used for working capital, capital expenditures, permitted acquisitions and other general corporate purposes.
Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Tiffany McGee, Assistant General Counsel, Commercial Contracts, has been named to The Software Report’s 2025 list of the Top Women Leaders in Software.
